Skip to content
TrialScanner

NCT02547623

Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery

Phase 3CompletedICLRLead

Registry record

Lead sponsor
ICON Bioscience Inc
Conditions
Cataract
Primary completion
Aug 16, 2016Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02547623 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.